TN2016000479A1 - Nitisinone dosing regimens for the treatment of alkaptonuria. - Google Patents
Nitisinone dosing regimens for the treatment of alkaptonuria.Info
- Publication number
- TN2016000479A1 TN2016000479A1 TN2016000479A TN2016000479A TN2016000479A1 TN 2016000479 A1 TN2016000479 A1 TN 2016000479A1 TN 2016000479 A TN2016000479 A TN 2016000479A TN 2016000479 A TN2016000479 A TN 2016000479A TN 2016000479 A1 TN2016000479 A1 TN 2016000479A1
- Authority
- TN
- Tunisia
- Prior art keywords
- nitisinone
- alkaptonuria
- treatment
- dosing regimens
- administered
- Prior art date
Links
- OUBCNLGXQFSTLU-UHFFFAOYSA-N nitisinone Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=CC=C1C(=O)C1C(=O)CCCC1=O OUBCNLGXQFSTLU-UHFFFAOYSA-N 0.000 title abstract 6
- 229960001721 nitisinone Drugs 0.000 title abstract 5
- 206010001689 alkaptonuria Diseases 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1450521 | 2014-04-30 | ||
| PCT/EP2015/059352 WO2015165972A1 (en) | 2014-04-30 | 2015-04-29 | Nitisinone dosing regimens for the treatment of alkaptonuria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2016000479A1 true TN2016000479A1 (en) | 2018-04-04 |
Family
ID=53175441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TN2016000479A TN2016000479A1 (en) | 2014-04-30 | 2015-04-29 | Nitisinone dosing regimens for the treatment of alkaptonuria. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20170049716A1 (enExample) |
| EP (1) | EP3137066A1 (enExample) |
| JP (1) | JP2017514820A (enExample) |
| AU (1) | AU2015254669A1 (enExample) |
| BR (1) | BR112016024756A2 (enExample) |
| CA (1) | CA2947062A1 (enExample) |
| IL (1) | IL248506A0 (enExample) |
| MA (1) | MA39918A (enExample) |
| SG (1) | SG11201608957VA (enExample) |
| TN (1) | TN2016000479A1 (enExample) |
| WO (1) | WO2015165972A1 (enExample) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2723320B1 (en) | 2011-06-23 | 2016-01-13 | Swedish Orphan Biovitrum International AB | Liquid pharmaceutical composition comprising nitisinone |
-
2015
- 2015-04-29 AU AU2015254669A patent/AU2015254669A1/en not_active Abandoned
- 2015-04-29 SG SG11201608957VA patent/SG11201608957VA/en unknown
- 2015-04-29 WO PCT/EP2015/059352 patent/WO2015165972A1/en not_active Ceased
- 2015-04-29 TN TN2016000479A patent/TN2016000479A1/en unknown
- 2015-04-29 BR BR112016024756A patent/BR112016024756A2/pt not_active IP Right Cessation
- 2015-04-29 JP JP2016564948A patent/JP2017514820A/ja active Pending
- 2015-04-29 MA MA039918A patent/MA39918A/fr unknown
- 2015-04-29 CA CA2947062A patent/CA2947062A1/en not_active Abandoned
- 2015-04-29 US US15/307,622 patent/US20170049716A1/en not_active Abandoned
- 2015-04-29 EP EP15722113.6A patent/EP3137066A1/en not_active Withdrawn
-
2016
- 2016-10-26 IL IL248506A patent/IL248506A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015165972A1 (en) | 2015-11-05 |
| IL248506A0 (en) | 2016-12-29 |
| AU2015254669A1 (en) | 2016-12-15 |
| JP2017514820A (ja) | 2017-06-08 |
| MA39918A (fr) | 2017-03-08 |
| US20170049716A1 (en) | 2017-02-23 |
| SG11201608957VA (en) | 2016-11-29 |
| CA2947062A1 (en) | 2015-11-05 |
| BR112016024756A2 (pt) | 2017-08-15 |
| EP3137066A1 (en) | 2017-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2018004776A2 (es) | Composiciones terapéuticas para el tratamiento del virus de inmunodeficiencia humana | |
| PL3936130T3 (pl) | Schemat dawkowania walbenazyny w leczeniu hiperkinetycznych zaburzeń ruchu | |
| IL258246B (en) | Isolidine compound, pharmaceutical compositions comprising same, their combinations with therapeutic agents for use in the treatment of cancer | |
| MX2017002816A (es) | Derivados de pirazolopiridina y su uso en terapia. | |
| CL2015001610A1 (es) | Compuestos derivados de pirimido-[4,5-b]-quinolina-4,5(3h,10h)-dionas para utilizarse como un medicamento para el tratamiento de una enfermedad causada por una mutacion sin sentido; composicion y combinacion farmaceutica que los comprende. | |
| ECSP16084317A (es) | Formulaciones farmacéuticas, procesos para la preparación y métodos de uso | |
| MX2017005484A (es) | Compuestos antagonistas del receptor de dopamina d3. | |
| EA201692111A1 (ru) | Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний | |
| MX2016006087A (es) | Formulaciones de desintegracion rapida y metodos de uso. | |
| PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
| SI3258920T1 (sl) | Trdna farmacevtska oblika za odmerjanje, primerna za uporabo kot zdravilo za pitno vodo | |
| PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
| AR093327A1 (es) | Analogos quimericos de somatostatina-dopamina | |
| ECSP17022124A (es) | Composición farmacéutica sólida que comprende amlodipino y losartán | |
| MD20180049A2 (ro) | Compoziţie farmaceutică | |
| EA201790020A1 (ru) | Соединения, фармацевтические композиции и их применение при лечении нейродегенеративных заболеваний | |
| TN2016000479A1 (en) | Nitisinone dosing regimens for the treatment of alkaptonuria. | |
| MA39009A (fr) | Compositions pharmaceutiques comprenant un agent actif | |
| EP2866555A4 (en) | DOSAGE SCHEME FOR THE TREATMENT OF ANIMALS | |
| CU20180036A7 (es) | Composiciones terapéuticas para el tratamiento del virus de la inmunodeficiencia humana | |
| UA88138U (ru) | Лекарственное средство в форме перорального раствора для лечения и профилактики ишемии тканей организма | |
| ITUB20153076A1 (it) | Composti farmaceuticamente attivi per l?impiego nel trattamento terapeutico di disturbi del movimento. | |
| UA112089C2 (uk) | Тверда лікарська форма комбінованого препарату седативної та снодійної дії, що містить доксиламін | |
| CL2015001705A1 (es) | Uso de pidotimod para tratar la psoriasis |